TELL ME MORE
ABOUT THIS CLINICAL TRIAL FOR DIABETES IN ADULTS WITH CV RISK FACTORS
This is an Active Comparitor Study of a Dual Action versus Single Action Investigational Medicine on Glucose Control and Cardiovascular Events in Adults Age 40+ living with Type 2 Diabetes and CV Risk Factors
Clinical Trial for Diabetes in Adults with CV Risk Factors
Study Location(s): Owensboro and Bowling Green Kentucky
Type 2 diabetes is the most common form of diabetes—and it means that your body doesn’t use insulin properly. And while some people can control their blood sugar levels with healthy eating and exercise, others may need medication or insulin to help manage it. This phase 3 study compares a dual action investigational medicine to a single action glucagon-like peptide-1 (GLP-1) receptor agonist (RA) in adults 40 years and older, living with Type 2 Diabetes and cardiovascular risk factors. Click here for more information on living with Diabetes.
There is no cost to participate. Volunteers receive free investigational medicine and follow-up care. No insurance needed. Time and travel reimburrsement up to $600 per year may be available. This is a multi-year study.
View More Studies
| Condition | Location | Status | Age Range | Sex | Max Compensation | |
|---|---|---|---|---|---|---|
| ACNE HYPERPIGMENTATION Trifarotene Cream used versus another cream to treat acne-induced hyperpigmentation | Evansville | Enrolling | 13-35 | $750 | Request Info | |
| ADHD A Long-term active comparitor and dose optimization study to evaluate safety and efficacy of a non-stimulat medication | Bowling Green Owensboro | Enrolling | 6 - 17 | $1150 | Request Info | |
| COPD A Phase 3 Study to Evaluate the Efficacy and Safety of Two Dose Regimens of an Investigational Medication in Participants with Symptomatic COPD | Bowling Green | Enrolling | 40+ | Up to $1200 | Request Info | |
| COPD Safety, Efficacy and Tolerance study for moderate to severe COPD | Owensboro | Enrolling | 40-85 | Up to $750 | Request Info | |
| DIABETES (T2DM) Safety and Efficacy of an Investigational Medicine for pediatric and adolescent patients with type 2 diabetes. | Evansville | Enrolling | 10-17 | Up to $875 | Request Info | |
| DIABETES (T2DM) Study to Evaluate the Efficacy and Safety of an Investigation Medication as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults with Type 2 Diabetes | Bowling Green Evansville Owensboro | Coming Soon | 18 Years & Up | $1625 | Request Info | |
| ECZEMA (Atopic Dermatitis) Safety and efficacy, placebo-controlled study of a topical investigational medicine with open-label extension in patients with moderate to severe eczema | Owensboro | Enrolling | 2+ (child through adult) | $490 | Request Info | |
| ECZEMA (Atopic Dermatitis) Safety and efficacy, placebo-controlled study of a topical investigational medicine with open-label extension in patients with moderate to severe eczema | Evansville | Enrolling | 2+ (child through adult) | $560 - $1400 | Request Info | |
| IBD - CROHN'S DISEASE A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Crohn's Disease | Owensboro Evansville | Enrolling | 18 - 80 | $3200 | Request Info | |
| IBD - ULCERATIVE COLITIS A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Ulcerative Colitis | Evansville | Enrolling | 18 - 80 | $1100 | Request Info | |
| INFANT FORMULA & BREASTFEEDING Infant Formula for Healthy Babies | Evansville Owensboro | Enrolling | Newborns | $625 + formula | Request Info | |
| LUPUS (SLE) A Randomized, Placebo-Controlled Clinical Trial for the Treatment of Systemic Lupus Erythematosus | Evansville | Enrolling | 18 - 65 | $800 | Request Info | |
| LUPUS NEPHRITIS A Safety, efficacy and tolerability study for patients with active Lupus Nephritis | Evansville | Enrolling | 18 - 75 | $4625 ($125 per visit) | Request Info | |
| MIGRAINES in CHILDREN A Double Blind, Placebo Controlled Study of an Investigational Medicine for Pediatric Migraines | BowlingGreen Owensboro Evansville | Enrolling | 6 - 17 | $200/$350 | Request Info | |
| MENINGOCOCCAL VACCINE Safety and Immunogenicity of a Meningococcal B vaccine when Administered Together with the MENVEO (MenACWY) Vaccine in healthy subjects age 16 - 18 | Evansville | Enrolling | 16-18 | $300 | Request Info | |
| PSORIASIS A Double-blind, Placebo-controlled Study to Investigate the Efficacy of an Investigational Oral Medication of Moderate to Severe Plaque Psoriasis | Owensboro Evansville | Enrolling | 18-75 | Up to $585 | Request Info | |